Literature DB >> 8402882

Following a diabetogenic T cell from genesis through pathogenesis.

J D Katz1, B Wang, K Haskins, C Benoist, D Mathis.   

Abstract

Nonobese diabetic (NOD) mice spontaneously develop a disease very similar to type 1 diabetes in humans. We have generated a transgenic mouse strain carrying the rearranged T cell receptor genes from a diabetogenic T cell clone derived from a NOD mouse. Self-reactive T cells expressing the transgene-encoded specificity are not tolerized in these animals, resulting in rampant insulitis and eventually diabetes. Features of the disease process emphasize two so-called check-points, recognized previously in the NOD and human diseases but easily misinterpreted. Although NOD mice are protected from insulitis and diabetes by expression of the E molecule encoded in the major histocompatibility complex, the transgenics are not, permitting us to exclude some possible mechanisms of protection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8402882     DOI: 10.1016/0092-8674(93)90730-e

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  264 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Regulation of development and function of memory CD4 subsets.

Authors:  L M Bradley; J Harbertson; G C Freschi; R Kondrack; P J Linton
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 4.  Membrane domains and the immunological synapse: keeping T cells resting and ready.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells.

Authors:  Lili Yang; Xiao-Feng Qin; David Baltimore; Luk Van Parijs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

6.  Stability of the regulatory T cell lineage in vivo.

Authors:  Yuri P Rubtsov; Rachel E Niec; Steven Josefowicz; Li Li; Jaime Darce; Diane Mathis; Christophe Benoist; Alexander Y Rudensky
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

7.  A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.

Authors:  Stephen T Ferris; Javier A Carrero; James F Mohan; Boris Calderon; Kenneth M Murphy; Emil R Unanue
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

8.  Single-cell mass cytometry of TCR signaling: amplification of small initial differences results in low ERK activation in NOD mice.

Authors:  Michael Mingueneau; Smita Krishnaswamy; Matthew H Spitzer; Sean C Bendall; Erica L Stone; Stephen M Hedrick; Dana Pe'er; Diane Mathis; Garry P Nolan; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

9.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

10.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.